- PR Newswire•12 days ago
RADNOR, Pa., Feb. 13, 2017 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE: SFE) Senior Vice President and Chief Financial Officer, Jeffrey B. McGroarty , will present at the 2 nd Annual Disruptive ...
- PR Newswire•17 days ago
MADISON, Wis., Feb. 8, 2017 /PRNewswire/ -- Propeller Health, the leading digital health solution for respiratory medicine, and Novartis Pharma AG (NVS) today announced a collaboration to develop a custom add-on sensor for the Breezhaler™ inhaler, a device used for the company's portfolio of COPD treatments (Ultibro™ Breezhaler™, Onbrez™ Breezhaler™ and Seebri™ Breezhaler™), connecting these medications to Propeller's digital health platform. As patients use the Breezhaler™ inhaler, a patented capsule-based dry powder inhaler (DPI) for treatment of COPD, the new custom sensors will allow for passively recording and transmitting compliance data, better informing patients and their physicians of adherence and other treatment factors through the Propeller platform. Propeller has regulatory clearance to help patients and their physicians better understand asthma and COPD, and help to improve the symptoms and outcomes of these chronic respiratory diseases.
- PR Newswire•23 days agoSafeguard Scientifics to Release Fourth Quarter and Full-Year 2016 Financial Results on Thursday, March 2nd
RADNOR, Pa., Feb. 2, 2017 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the fourth quarter and full-year ended December 31, 2016 prior to market open ...
SFE : Summary for Safeguard Scientifics, Inc. New - Yahoo Finance
Safeguard Scientifics, Inc. (SFE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||12.00 x 400|
|Ask||20.05 x 500|
|Day's Range||12.75 - 12.80|
|52 Week Range||10.60 - 14.75|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-17.61|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|